Oncogene - Table of Contents alert Volume 36 Issue 2

If you are unable to see the message below, click here to view.

Advertisement Think ChIP is hard? We make it easy! ChIP and ChIP-seq - easy kits, even for beginners. Validated ChIP antibodies - they work the first time!  Bioruptor chromatin shearing systems - cited over 2,000 times.  ChIP/ChIP-seq automation        Learn more Learn more should go to http://www.diagenode.com?utm_source=Oncogene&utm_medium=email&utm_content=&utm_campaign=Diagenode_all   TABLE OF CONTENTS Volume 36, Issue 2 (January 2017) In this issue Reviews Original Articles Short Communication Corrigendum Also new AOP Sign up for e-alerts Recommend to your library Web feed Subscribe   Advertisement nature.com webcasts Springer Nature presents a custom webcast on: Liquid biopsy: CTC-based classifier predicts chemo resistance in lung cancer Date: Thursday January 19 2017 Time: 8AM PST, 11AM EST, 4PM GMT, 5PM CET  Register for FREE Sponsored by:  Menarini Silicon Biosystems     Reviews Top Metabolic rewiring in melanoma B I Ratnikov, D A Scott, A L Osterman, J W Smith and Z A Ronai Oncogene 2017 36: 147-157; advance online publication, June 6, 2016; 10.1038/onc.2016.198 Abstract | Full Text Base changes in tumour DNA have the power to reveal the causes and evolution of cancer OPEN M Hollstein, L B Alexandrov, C P Wild, M Ardin and J Zavadil Oncogene 2017 36: 158-167; advance online publication, June 6, 2016; 10.1038/onc.2016.192 Abstract | Full Text Original Articles Top Elevated STAT3 expression in ovarian cancer ascites promotes invasion and metastasis: a potential therapeutic target U Saini, S Naidu, A C ElNaggar, H K Bid, J J Wallbillich, K Bixel, C Bolyard, A A Suarez, B Kaur, P Kuppusamy, J Hays, P J Goodfellow, D E Cohn and K Selvendiran Oncogene 2017 36: 168-181; advance online publication, June 13, 2016; 10.1038/onc.2016.197 Abstract | Full Text REC8 functions as a tumor suppressor and is epigenetically downregulated in gastric cancer, especially in EBV-positive subtype OPEN J Yu, Q Liang, J Wang, K Wang, J Gao, J Zhang, Y Zeng, P W Y Chiu, E K W Ng and J J Y Sung Oncogene 2017 36: 182-193; advance online publication, May 23, 2016; 10.1038/onc.2016.187 Abstract | Full Text The FEN1 L209P mutation interferes with long-patch base excision repair and induces cellular transformation OPEN H Sun, L He, H Wu, F Pan, X Wu, J Zhao, Z Hu, C Sekhar, H Li, L Zheng, H Chen, B H Shen and Z Guo Oncogene 2017 36: 194-207; advance online publication, June 6, 2016; 10.1038/onc.2016.188 Abstract | Full Text Amplification of R-spondin1 signaling induces granulosa cell fate defects and cancers in mouse adult ovary OPEN M-C De Cian, E Pauper, R Bandiera, V P I Vidal, S Sacco, E P Gregoire, A-A Chassot, C Panzolini, D Wilhelm, E Pailhoux, S A Youssef, A de Bruin, K Teerds, A Schedl, I Gillot and M-C Chaboissier Oncogene 2017 36: 208-218; advance online publication, June 6, 2016; 10.1038/onc.2016.191 Abstract | Full Text Foxp3 is a key downstream regulator of p53-mediated cellular senescence J-E Kim, J-S Shin, J-H Moon, S-W Hong, D-J Jung, J H Kim, I-Y Hwang, Y J Shin, E-Y Gong, D H Lee, S-M Kim, E Y Lee, Y S Kim, D Kim, D Hur, T W Kim, K-p Kim, D-H Jin and W-J Lee Oncogene 2017 36: 219-230; advance online publication, May 30, 2016; 10.1038/onc.2016.193 Abstract | Full Text MiR-26a inhibits stem cell-like phenotype and tumor growth of osteosarcoma by targeting Jagged1 J Lu, G Song, Q Tang, J Yin, C Zou, Z Zhao, X Xie, H Xu, G Huang, J Wang, D-F Lee, R Khokha, H Yang and J Shen Oncogene 2017 36: 231-241; advance online publication, June 6, 2016; 10.1038/onc.2016.194 Abstract | Full Text The ERK–ZEB1 pathway mediates epithelial–mesenchymal transition in pemetrexed resistant lung cancer cells with suppression by vinca alkaloids OPEN L-Y Chiu, I-L Hsin, T-Y Yang, W-W Sung, J-Y Chi, J T Chang, J-L Ko and G-T Sheu Oncogene 2017 36: 242-253; advance online publication, June 6, 2016; 10.1038/onc.2016.195 Abstract | Full Text Targeting 6-phosphogluconate dehydrogenase in the oxidative PPP sensitizes leukemia cells to antimalarial agent dihydroartemisinin S Elf, R Lin, S Xia, Y Pan, C Shan, S Wu, S Lonial, M Gaddh, M L Arellano, H J Khoury, F R Khuri, B H Lee, T J Boggon, J Fan and J Chen Oncogene 2017 36: 254-262; advance online publication, June 6, 2016; 10.1038/onc.2016.196 Abstract | Full Text PRMT5–PTEN molecular pathway regulates senescence and self-renewal of primary glioblastoma neurosphere cells Y K Banasavadi-Siddegowda, L Russell, E Frair, V A Karkhanis, T Relation, J Y Yoo, J Zhang, S Sif, J Imitola, R Baiocchi and B Kaur Oncogene 2017 36: 263-274; advance online publication, June 13, 2016; 10.1038/onc.2016.199 Abstract | Full Text miR-374a-CCND1-pPI3K/AKT-c-JUN feedback loop modulated by PDCD4 suppresses cell growth, metastasis, and sensitizes nasopharyngeal carcinoma to cisplatin Y Zhen, W Fang, M Zhao, R Luo, Y Liu, Q Fu, Y Chen, C Cheng, Y Zhang and Z Liu Oncogene 2017 36: 275-285; advance online publication, June 6, 2016; 10.1038/onc.2016.201 Abstract | Full Text Short Communication Top A platform for interrogating cancer-associated p53 alleles A D'Brot, P Kurtz, E Regan, B Jakubowski and J M Abrams Oncogene 2017 36: 286-291; advance online publication, March 21, 2016; 10.1038/onc.2016.48 Abstract | Full Text Corrigendum Top A platform for interrogating cancer-associated p53 alleles A D'Brot, P Kurtz, E Regan, B Jakubowski and J M Abrams Oncogene 2017 36: 292; advance online publication, December 19, 2016; 10.1038/onc.2016.190 Full Text Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Oncogene. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW. © 2017 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.